NovoCure Limited
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $96.2M | $142.3M | $99.8M |
| FY2017 | $97.3M | $113.6M | $78.6M |
| FY2018 | $149.3M | $112.3M | $140.6M |
| FY2019 | $149.4M | $217.8M | $177.3M |
| FY2020 | $429.9M | $476.5M | $234.7M |
| FY2021 | $562.2M | $410.5M | $208.8M |
| FY2022 | $565.5M | $441.2M | $115.3M |
| FY2023 | $568.8M | $362.5M | $240.8M |
| FY2024 | $97.3M | $360.2M | $163.8M |
| FY2025 | $195.0M | $340.5M | $93.5M |